Publicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (206)

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  3. Endovascular thrombectomy first-pass reperfusion and ancillary device placement

    Journal of NeuroInterventional Surgery

  4. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain

    Dermatitis, Vol. 34, Núm. 4, pp. 315-322

  5. Primary Percutaneous Coronary Intervention in Patients With Spontaneous Coronary Artery Dissection vs Coronary Artery Disease

    JACC. Cardiovascular interventions, Vol. 16, Núm. 15, pp. 1860-1869

  6. Radiation protection in interventional echocardiography. Recommendations of the SEC-Cardiovascular Imaging Association/SEC-Interventional Cardiology Association

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 956-960

  7. Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 214-217

  8. The three-noes right-sided infective endocarditis: An unrecognized type of right-sided endocarditis

    Medicine, Vol. 102, Núm. 29, pp. e34322

  9. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

    Journal of Medical Virology, Vol. 95, Núm. 12

  10. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

  11. What's New in the 2022 Consensus for Severe Asthma in Adults

    Archivos de Bronconeumologia

  12. “Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study”

    European Journal of Surgical Oncology, Vol. 49, Núm. 10